Changeflow GovPing Healthcare Monitoring Assay Performance
Routine Notice Added Final

Monitoring Assay Performance

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Health Informatics (G16H)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4639562A1 for Genentech, Inc., titled 'Monitoring Assay Performance.' The invention relates to methods and systems for monitoring assay performance and quality control in healthcare diagnostics. The patent was published March 25, 2026, with designated states covering all EPC contracting states.

What changed

The EPO published Genentech's patent application EP4639562A1 for methods of monitoring assay performance and quality control. The invention is classified under G16H 10/40 (health informatics for diagnosis), G16H 50/30 (health informatics for quality control), G06F 17/18 (statistical analysis), and G01N 33/00 (chemical analysis). The designated states include all 44 EPC contracting states covering the European Union member states plus other European countries.

This is a patent publication notice with no regulatory compliance requirements. Entities in the pharmaceutical, biotechnology, or medical device sectors should note this intellectual property filing for competitive intelligence and freedom-to-operate analysis purposes. No action is required for regulatory compliance. Patent protection, if granted, would provide exclusivity in the designated contracting states.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

MONITORING ASSAY PERFORMANCE

Publication EP4639562A1 Kind: A1 Mar 25, 2026

Applicants

Genentech, Inc.

Inventors

USDIN, Maxime Steve

IPC Classifications

G16H 10/40 20180101AFI20240629BHEP G16H 50/30 20180101ALI20240629BHEP G06F 17/18 20060101ALI20240629BHEP G01N 33/00 20060101ALI20240629BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for ChangeBridge: EPO Bulletin - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4639562A1

Who this affects

Applies to
Pharmaceutical companies Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Patent Filing Diagnostic Technology
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Health Informatics (G16H) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.